AWA
RXST icon

Arete Wealth Advisors’s RxSight RXST Stock Holding History

Arete Wealth Advisors’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-4,405
Closed -$215K – 783
2024
Q3 		$215K Buy
+4,405
New +$226K 0.02% 631

Other funds holding RXST

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Arete Wealth Advisors's RXST Position: Q4 2024 in Review

Arete Wealth Advisors sold out of RxSight (RXST) in Q4 2024, closing a stake of 4,405 shares — an estimated $215K sold.

Arete Wealth Advisors first reported a position in RXST in Q3 2024 and held it in 1 quarter. The position peaked at $215K in Q3 2024. 212 funds tracked by Wall St. Rank hold RXST as of Q4 2024.

  • Arete Wealth Advisors reported no remaining RxSight position as of Q4 2024 after selling out during the quarter.
  • Arete Wealth Advisors sold 4,405 RxSight shares in Q4 2024, an estimated $215K.
  • Arete Wealth Advisors first reported a position in RxSight in Q3 2024 and held it in 1 quarter.
  • Arete Wealth Advisors's RxSight position peaked at $215K in Q3 2024.
  • 212 funds tracked by Wall St. Rank held RxSight as of Q4 2024.

Based on Arete Wealth Advisors's 13F filing for Q4 2024, filed 12 Feb 2025.